Inflammatory bowel disease (IBD) represents a group of idiopathic chronic inflammatory intestinal conditions associated with various areas of the GI tract, including two types of inflammatory conditions, i.e., ulcerative colitis (UC) and Crohn's disease (CD). Both UC and CD are chronic inflammatory disorders of the intestine; in UC, inflammation starts in the rectum and generally extends proximally in a continuous manner through the entire colon. Bloody diarrhea, presence of blood and mucus mixed with stool, accompanied by lower abdominal cramping, are the characteristic symptoms of the disease. While in CD, inflammatory condition may affect any part of the GI tract from mouth to anus. It mainly causes abdominal pain, diarrhea, vomiting and weight loss. Although the basic etiology of IBD is unknown, there are several factors that may contribute to the pathogenesis of this disease, such as dysregulation of immune system or commensal bacteria, oxidative stress and inflammatory mediators. In order to understand these different etiological factors, a number of experimental models are available in the scientific research, including chemical-induced, spontaneous, genetically engineered and transgenic models. These models represent a major source of information about biological systems and are clinically relevant to the human IBD. Since there is less collective data available in one single article discussing about all these models, in this review an effort is made to study the outline of pathophysiology and various types of animal models used in the research study of IBD and other disease-related complications.

The stress-activated p38 mitogen-activated protein kinase (p38 MAPK), a member of the subgroup of mammalian kinases, appears to play an important role in regulating inflammatory responses, including cytokine secretion and apoptosis. The upstream mediators that link extracellular signals with the p38 MAPK signaling pathway are currently unknown. Here we demonstrate that pp125 focal adhesion kinase-related tyrosine kinase RAFTK (also known as PYK2, CADTK) is activated specifically by methylmethane sulfonate (MMS) and hyperosmolarity but not by ultraviolet radiation, ionizing radiation, or cis-platinum. Overexpression of RAFTK leads to the activation of p38 MAPK. Furthermore, overexpression of a dominant-negative mutant of RAFTK (RAFTK K-M) inhibits MMS-induced p38 MAPK activation. MKK3 and MKK6 are known potential constituents of p38 MAPK signaling pathway, whereas SEK1 and MEK1 are upstream activators of SAPK/JNK and ERK pathways, respectively. We observe that the dominantnegative mutant of MKK3 but not of MKK6, SEK1, or MEK1 inhibits RAFTK-induced p38 MAPK activity. Furthermore, the results demonstrate that treatment of cells with 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid, tetra(acetoxymethyl)-ester, a membranepermeable calcium chelator, inhibits MMS-induced activation of RAFTK and p38 MAPK. Taken together, these findings indicate that RAFTK represents a stress-sensitive mediator of the p38 MAPK signaling pathway in response to certain cytotoxic agents.The mitogen-activated protein kinases (MAPKs) 1 are induced in response to diverse classes of inducers in the transduction of signals from the cell membrane to the nucleus. MAPKs are proline-directed Ser/Thr protein kinases that are regulated by extracellular signals including growth factors and cellular stress (1-3). The well characterized MAPK subfamily includes ERK1 and ERK2, which are activated by growth factors via the conserved Ras/Raf/MEK pathway (4 -7).c-Jun N-terminal protein kinases (JNKs) or stress-activated protein kinases (SAPKs) represent a second class of the mammalian MAPKs, which are primarily activated in response to tumor necrosis factor, interleukin-1, UV-, and DNA-damaging agents (5, 8 -11). A recently identified novel protein tyrosine kinase, related adhesion focal tyrosine kinase (RAFTK) (12) (also known as Pyk2, Refs. 13 and 14); CADTK, Ref. 15) has been shown to be involved upstream to ERKs and JNK signaling pathways (14,16). RAFTK is also a close relative to pp125 FAK tyrosine kinase and is activated by various extracellular signals that increase intracellular calcium concentrations (13). Moreover, RAFTK can tyrosine phosphorylate and modulate the action of ion channels and appears to function as an intermediate that links various calcium signals with both short-and long-term responses in neuronal cells (13).An additional class, which presents substantial similarity to the Saccharomyces cerevisiae HOG1 kinase involved in response to increased extracellular osmolarity (17), is p38 MAPK. p38 MAPK can also be activated by chan...

The caspase family of proteases plays a critical role in the execution of apoptosis. However, efforts to decipher the molecular mechanisms by which caspases induce cell death have been greatly hindered by the lack of systematic and broadly applicable strategies to identify their substrates. Here we describe a novel expression cloning strategy to rapidly isolate cDNAs encoding caspase substrates that are cleaved during apoptosis. Small cDNA pools (approximately 100 clones each) are transcribed/translated in vitro in the presence of [ 35 S]methionine; these labeled protein pools are then incubated with cytosolic extracts from control and apoptotic cells. cDNA pools encoding proteins that are specifically cleaved by the apoptotic extract and whose cleavage is prevented by the caspase inhibitor acetylTyr-Val-Ala-Asp chloromethylketone are subdivided and retested until a single cDNA is isolated. Using this approach, we isolated a partial cDNA encoding protein kinase C-related kinase 2 (PRK2), a serine-threonine kinase, and demonstrate that full-length human PRK2 is proteolyzed by caspase-3 at Asp 117 and Asp 700 in vitro. In addition, PRK2 is cleaved rapidly during Fas-and staurosporine-induced apoptosis in vivo by caspase-3 or a closely related caspase. Both of the major apoptotic cleavage sites of PRK2 in vivo lie within its regulatory domain, suggesting that its activity may be deregulated by proteolysis.Caspases are a novel family of cysteine proteases with aspartate specificity that are related to the Caenorhabditis elegans cell death gene product CED-3. Evidence from many laboratories indicates that caspases play a critical role in the execution of apoptosis. Ectopic expression of these proteases induces programmed cell death. Caspases are normally present in cells as catalytically inactive proenzymes and are proteolytically processed and activated during the induction of apoptosis. Moreover, viral, peptide, and dominant negative inhibitors of caspases delay or prevent programmed cell death (reviewed in Ref. 1). Finally, homozygous inactivation of caspase-1 (2) and caspase-3 (3) in mice results in selective defects in apoptosis.Because caspase activation is a crucial event in apoptosis, it is essential to identify the downstream molecular targets of these proteases whose selective proteolysis is likely to underlie the characteristic morphological features of apoptotic cell death. Although a number of structural and signaling proteins have been shown to be cleaved by caspases during programmed cell death (reviewed in Ref. 4), our understanding of the molecular mechanisms by which caspases induce cell death has been greatly hindered by the lack of systematic and broadly applicable strategies to identify these substrates. Given the absence of such methods and the growing number of caspase family members, it seems likely that the majority of apoptotic caspase targets have yet to be identified.In this report, we describe a method to identify caspase substrates directly and rapidly using labeled protein pools derived...

No abstract